MLYS · Forms 3, 4, 5

Insider trades at Mineralys Therapeutics, Inc.

3 insiders sold $5.1M of Mineralys Therapeutics, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Mineralys Therapeutics, Inc. (MLYS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Jon CongletonChief Executive OfficerSell (10b5-1 plan)75,000$25.46$1.9MForm 4
Brian Taylor SlingsbyDirectorSell104,320$28.81$3MForm 4
Eric WarrenChief Commercial OfficerOption exercise7,438$13.24$98KForm 4
Eric WarrenChief Commercial OfficerSell (10b5-1 plan)7,438$28.12$209KForm 4
Daphne KarydasDirectorOption exercise3,000$12.02$36KForm 4
Daphne KarydasDirectorSell (10b5-1 plan)3,000$28.58$86KForm 4
Eric WarrenChief Commercial OfficerOption exercise7,437$13.24$98KForm 4
Eric WarrenChief Commercial OfficerSell (10b5-1 plan)7,437$25.98$193KForm 4
James J. Ferguson IIIChief Medical OfficerBecame an insider (Form 3)Form 3
James J. Ferguson IIIChief Medical OfficerAward102,400Form 4
David Malcom RodmanChief Medical OfficerOption exercise2,170$16.00$35KForm 4
David Malcom RodmanChief Medical OfficerSell (10b5-1 plan)2,170$27.09$59KForm 4
Eric WarrenChief Commercial OfficerOption exercise7,438$13.24$98KForm 4
Eric WarrenChief Commercial OfficerSell (10b5-1 plan)7,438$26.87$200KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.